Repare Therapeutics Inc. (RPTX) Misses Q4 EPS by 31c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q4 EPS of ($0.67), $0.31 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $13.05 million versus the consensus estimate of $25.1 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Brinker International (EAT) Misses Q4 EPS by 2c ; Offers Guidance
• Global-e Online (GLBE) Tops Q2 EPS by 16c ; Offers Guidance
• Annexon, Inc. (ANNX) Misses Q2 EPS by 4c